These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Peripheral and mesencephalic transfer of a synthetic gene for the thymic peptide thymulin. Morel GR; Brown OA; Reggiani PC; Hereñú CB; Portiansky EL; Zuccolilli GO; Pléau JM; Dardenne M; Goya RG Brain Res Bull; 2006 May; 69(6):647-51. PubMed ID: 16716832 [TBL] [Abstract][Full Text] [Related]
11. Gene therapy for long-term restoration of circulating thymulin in thymectomized mice and rats. Reggiani PC; Hereñú CB; Rimoldi OJ; Brown OA; Pléau JM; Dardenne M; Goya RG Gene Ther; 2006 Aug; 13(16):1214-21. PubMed ID: 16617301 [TBL] [Abstract][Full Text] [Related]
12. Thymulin-based gene therapy and pituitary function in animal models of aging. Reggiani PC; Poch B; Cónsole GM; Rimoldi OJ; Schwerdt JI; Tüngler V; Garcia-Bravo MM; Dardenne M; Goya RG Neuroimmunomodulation; 2011; 18(5):350-6. PubMed ID: 21952687 [TBL] [Abstract][Full Text] [Related]
13. Potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models. Morel GR; Reggiani PC; Console GM; Rimoldi OJ; Vesenbeckh SM; Garcia-Bravo MM; Rodriguez SS; Brown OA; Goya RG Curr Gene Ther; 2008 Feb; 8(1):49-53. PubMed ID: 18336249 [TBL] [Abstract][Full Text] [Related]
14. Thymus and aging: potential of gene therapy for restoration of endocrine thymic function in thymus-deficient animal models. Goya RG; Cónsole G; Hereñú C; Brown O; Rimoldi OJ Gerontology; 2002; 48(5):325-8. PubMed ID: 12169800 [TBL] [Abstract][Full Text] [Related]
15. Effects of injecting thymulin into the anterior or medial hypothalamus or the pituitary on induced ovulation in prepubertal mice. García L; Hinojosa L; Domínguez R; Chavira R; Rosas P Neuroimmunomodulation; 2005; 12(5):314-20. PubMed ID: 16166812 [TBL] [Abstract][Full Text] [Related]
16. A new adenovector system for implementing thymulin gene therapy for inflammatory disorders. Zappa-Villar MF; López-León M; Pardo J; Costa M; Crespo R; Dardenne M; Goya RG; Reggiani PC Mol Immunol; 2017 Jul; 87():180-187. PubMed ID: 28501652 [TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of neuromedin B in pituitary corticotrophs of male melanocortin 2 receptor-deficient mice. Kameda H; Miyoshi H; Shimizu C; Nagai S; Nakamura A; Kondo T; Chida D; Atsumi T Endocrinology; 2014 Jul; 155(7):2492-9. PubMed ID: 24742195 [TBL] [Abstract][Full Text] [Related]
18. Corticotropin-releasing hormone and the sympathoadrenal system are major mediators in the effects of peripherally administered exendin-4 on the hypothalamic-pituitary-adrenal axis of male rats. Gil-Lozano M; Romaní-Pérez M; Outeiriño-Iglesias V; Vigo E; González-Matías LC; Brubaker PL; Mallo F Endocrinology; 2014 Jul; 155(7):2511-23. PubMed ID: 24731096 [TBL] [Abstract][Full Text] [Related]
19. Recovery of the rat hypothalamic-pituitary-adrenal axis after discontinuation of prolonged treatment with the synthetic glucocorticoid agonist dexamethasone. Calogero AE; Kamilaris TC; Johnson EO; Tartaglia ME; Chrousos G Endocrinology; 1990 Oct; 127(4):1574-9. PubMed ID: 2169393 [TBL] [Abstract][Full Text] [Related]
20. Consequences of prenatal morphine exposure on the hypothalamo-pituitary-adrenal axis in the newborn rat: effect of maternal adrenalectomy. Lesage J; Grino M; Bernet F; Dutriez-Casteloot I; Montel V; Dupouy JP J Neuroendocrinol; 1998 May; 10(5):331-42. PubMed ID: 9663647 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]